HIF at the crossroads between ischemia and carcinogenesis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Tissue hypoxia occurs where there is an imbalance between oxygen supply and consumption in both, solid tumors as a result of exponential cellular proliferation and in atherosclerotic diseases as a result of inefficient blood supply. Hypoxia‐inducible factor 1 (HIF‐1) is central in normal angiogenesis and cancer angiogenesis. HIF‐1 is a transcriptional activator composed of an O 2‐ and growth factor‐regulated HIF‐1α subunit and a constitutively expressed HIF‐1β subunit. Upon activation, HIF‐1 drives the expression of genes controlling cell survival and governing the formation of new blood vessels. A better understanding of the regulation of HIF‐1α levels by the receptor tyrosine kinases/phosphatidylinositol 3‐kinase signaling pathway and by the HIF prolyl hydoxylases has provided new insights into the development of anticancer and revascularization therapeutics. We will focus on the potential of a new pharmacology for regulating HIF pathways in both, cancer and ischemic cardiac diseases. The consequences of the switch of HIF activation in these two disease states and the signaling pathway overlap that atherosclerosis and cancer angiogenesis share are discussed. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“…and growth factorregulated subunit HIF-1a, and the constitutively expressed HIF-1b subunit (arylhydrocarbon receptor nuclear translocator, ARNT), both of which belong to the basic helix-loop-helix (bHLH)–PAS (PER, ARNT, SIM) protein family (Brahimi-Horn et al., 2001; Semenza, 2001; Harris, 2002).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“…30 September 2003 DOI: 10.1002/jcp.10479 human HIF-1a protein) within the oxygen dependent degradation domain (ODDD) (Epstein et al., 2001a; Ivan et al., 2001), by specific HIF-prolyl hydroxylases (HPH13 also referred to as PHD1-3) (Bruick and McKnight, 2001; Epstein et al., 2001a; Metzen…”
BackgroundInfluentialEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385 · cited 2×
“Concurrently, hydroxylation of the asparagine residue 803 within the C-TAD also occurs by an asparaginyl hydroxylase (also referred to as FIH-1 (Mahon et al., 2001), which by its turn does not allow the coactivator p300/CBP to bind to HIF-1a subunit.”
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256 · cited 5×
“HER2 signaling stimulations by HER2 over expression or heregulin in human breast cancer cells results in increased HIF-1a protein and VEGF expression that is dependent upon activity of PI3K/AKT/FRAP (Laughner et al., 2001).”
BackgroundInfluentialHudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
Loss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
Wang, G., & Semenza, G. (1993) · Blood · doi:10.1182/blood.v82.12.3610.3610 · Cited by 766
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Vascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
Isaacs, J. S., Jung, Y.-J., Mimnaugh, E. G., Martinez, A., Cuttitta, F., & Neckers, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204733200 · Cited by 663 · cited 2×
“More recent discoveries have been added to support that Hsp90 chaperone activity is necessary for HIF-1 transcriptional activation and HIF-1a nuclear accumulation induced by hypoxia or heat (Suzuki et al., 2001; Isaacs et al., 2002; Katschinski et al., 2002; Mabjeesh et al., 2002).”
BackgroundYuan, Y., Hilliard, G., Ferguson, T., & Millhorn, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300463200 · Cited by 638
Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500 · cited 1×
“…Birner et al., 2000; Blancher et al., 2000; Achilles et al., 2001; Aebersold et al., 2001; Birner et al., 2001; Giatromanolaki et al., 2001; Beasley et al., 2002; Hui et al., 2002; Katschinski et al., 2002; Schindl et al., 2002; Sivridis et al., 2002; Sondergaard et al., 2002; Bos et al., 2003).”
BackgroundGiatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478 · cited 1×
“…neck cancers (Zhong et al., 1999; Birner et al., 2000; Blancher et al., 2000; Achilles et al., 2001; Aebersold et al., 2001; Birner et al., 2001; Giatromanolaki et al., 2001; Beasley et al., 2002; Hui et al., 2002; Katschinski et al., 2002; Schindl et al., 2002; Sivridis et al., 2002;…”
BackgroundGradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgård, R., Tora, L., Gassmann, M., & Poellinger, L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5221 · Cited by 470
Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Bürgel, T., Jelkmann, W., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00318 · Cited by 432 · cited 1×
“…within the oxygen dependent degradation domain (ODDD) (Epstein et al., 2001a; Ivan et al., 2001), by specific HIF-prolyl hydroxylases (HPH13 also referred to as PHD1-3) (Bruick and McKnight, 2001; Epstein et al., 2001a; Metzen et al., 2003) in the presence of iron, oxygen, and 2-oxoglutarate.”
BackgroundMAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370 · cited 1×
“Recently, a study showed that MAPK signaling may affect HIF activity not by directly affecting the activation of HIF-1a but rather by promoting the formation of the HIF-p300/CBP complex and by modulating the transactivation activity of p300/CBP itself (Sang et al., 2003).”
BackgroundMaynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., & Ohh, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208681200 · Cited by 283 · cited 1×
“So far in the human genome 3 isoforms of the a subunit of the transcription factor HIF have been identified: HIF-1a, HIF-2a (also referred to as EPAS-1, MOP2, HLF, and HRF), and HIF-3a (of which HIF-3a2 also referred to as IPAS, inhibitory PAS domain) (Maynard et al., 2003).”
BackgroundSivridis, E., Giatromanolaki, A., Gatter, K. C., Harris, A. L., Koukourakis, M. I., & for the Tumor and Angiogenesis Research Group (2002) · Cancer · doi:10.1002/cncr.10774 · Cited by 218 · cited 1×
“…Birner et al., 2000; Blancher et al., 2000; Achilles et al., 2001; Aebersold et al., 2001; Birner et al., 2001; Giatromanolaki et al., 2001; Beasley et al., 2002; Hui et al., 2002; Katschinski et al., 2002; Schindl et al., 2002; Sivridis et al., 2002; Sondergaard et al., 2002; Bos et al., 2003).”
BackgroundMack, F. A., Rathmell, W. K., Arsham, A. M., Gnarra, J., Keith, B., & Simon, M. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00240-4 · Cited by 160 · cited 1×
“An additional study provided indirect evidence in support that HIF is not necessarily a positive regulator of tumor growth where ES cells lacking VHL and constitutively expressing HIF-a subunits, did not promote teratocarcinoma growth (Mack et al., 2003).”
ResultZhao, Q., Egashira, K., Inoue, S., Usui, M., Kitamoto, S., Ni, W., Ishibashi, M., Hiasa, K.-I., Ichiki, T., Shibuya, M., et al. (2002) · Circulation · doi:10.1161/hc0902.104718 · Cited by 136 · cited 1×
“…of human cancers and their metastases compared to their adjacent normal tissue, including breast, prostate, brain, lung and head and neck cancers (Zhong et al., 1999; Birner et al., 2000; Blancher et al., 2000; Achilles et al., 2001; Aebersold et al., 2001; Birner et al., 2001; Giatromanolaki et…”
BackgroundNwogu, J. I., Geenen, D., Bean, M., Brenner, M. C., Huang, X., & Buttrick, P. M. (2001) · Circulation · doi:10.1161/hc4301.097193 · Cited by 131
Hur, E., Kim, H.-H., Choi, S. M., Kim, J. H., Yim, S., Kwon, H. J., Choi, Y., Kim, D. K., Lee, M.-O., & Park, H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.975 · Cited by 120 · cited 2×
“For instance, radicicol and the radicicol derivative, KF58333, inhibit the expression of HIF-1a, VEGF, and angiogenesis in human cancer cells, at least partially mediated by the inhibition of Hsp90 activity (Kurebayashi et al., 2001; Hur et al., 2002).”
BackgroundKurebayashi, J., Otsuki, T., Kurosumi, M., Soga, S., Akinaga, S., & Sonoo, H. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02159.x · Cited by 60
Cited by
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
The chemical biology of nitric oxide: Implications in cellular signaling
Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.020 · Cited by 975
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
“HIF-1 binds to the cysteine/ histidine-rich (CH1) domain of CBP/p300, and this interaction is necessary for HIF transcriptional activity (Paul et al., 2004).”
BackgroundRole of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
Metadata
- Authors
- Paul, S. A. M., Simons, J. W., & Mabjeesh, N. J.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2004-01-21
- Volume
- 200
- Issue
- 1
- Pages
- 20-30
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2030313478
- Cited by
- 121
- References
- 28
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.